Back to UBS Group AG UBS Group AG

PRQRPRQR
28 quarters

Position history for UBS Group AGUBS Group AG's holdings in PROQR THRAPEUTICS N V

UBS Group AG holds 639,243 shares of PRQR (PROQR THRAPEUTICS N V), worth $1.2M as of 2026-Q2. The position was increased (+109.4% shares). PRQR represents 0.0% of UBS Group AG's portfolio.

Current Value

$1.2M

Current Shares

639,243

Total Value Change

-$3.1M

Total Shares Change

+172,458

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
639,243
+109.4%
$1.2M0.0%$1.86
41
2026-Q1
Decreased
305,264
-61.7%
$494,5280.0%$1.50
0
2025-Q4
Increased
797,664
+743.6%
$1.6M0.0%$2.00
41
2025-Q3
Decreased
94,550
-91.7%
$201,3910.0%$2.19
0
2025-Q2
Decreased
1.1M
-36.0%
$2.3M0.0%$2.04
0
2025-Q1
Decreased
1.8M
-22.6%
$2.4M0.0%$1.40
0
2024-Q4
Increased
2.3M
+796x
$6.1M0.0%$2.65
44
2024-Q3
Decreased
2,900
-89.5%
$5,2780.0%$1.83
0
2024-Q2
Increased
27,546
+454.3%
$45,7260.0%$1.66
22
2024-Q1
Increased
4,970
+27.4%
$11,3810.0%$2.29
15
2023-Q4
Decreased
3,900
-61.2%
$7,7220.0%$1.98
0
2023-Q3
Increased
10,044
+114.6%
$13,0570.0%$1.30
19
2023-Q2
Increased
4,681
+30.0%
$7,5830.0%$1.62
14
2023-Q1
Increased
3,600
+22.3%
$7,6680.0%$1.99
13
2022-Q4
Decreased
2,944
-42.3%
$10,8930.0%$3.70
0
2022-Q3
New
5,098
-
$4,0000.0%$0.76
22
2022-Q1
Exited
0
-100.0%
$00.0%$0.90
0
2021-Q4
Decreased
84,327
-10.4%
$675,0000.0%$8.17
0
2021-Q3
Increased
94,116
+51.8%
$787,0000.0%$8.05
34
2021-Q2
Decreased
62,013
-31.6%
$418,0000.0%$6.76
0
2021-Q1
Decreased
90,615
-80.8%
$599,0000.0%$7.13
0
2020-Q4
Decreased
472,103
-1.3%
$2M0.0%$4.17
0
2020-Q3
Decreased
478,325
-0.8%
$2.3M0.0%$4.82
0
2020-Q2
Decreased
482,266
-0.1%
$2.9M0.0%$6.08
0
2020-Q1
Decreased
482,609
-5.0%
$2.7M0.0%$6.88
0
2019-Q4
Increased
507,886
+12.4%
$5M0.0%$9.45
30
2019-Q3
Decreased
451,693
-3.2%
$2.6M0.0%$6.20
0
2019-Q2
New
466,785
-
$4.2M0.0%$9.10
37

Other major holders of PRQR: ADAGE CAPITAL PARTNERS GP, L.L.C., RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used